儿科 COVID-19 治疗学：抓住正确的研发机会，加快儿童的治疗通道。
Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children.
机构信息
From the Medicines Patent Pool, Geneva, Switzerland.
Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
出版信息
Pediatr Infect Dis J. 2022 Jan 1;41(1):e1-e5. doi: 10.1097/INF.0000000000003331.
Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to collectively accelerate pediatric COVID-19 therapeutic research and development, based on the experience of the Global Accelerator for Paediatric Formulations.
儿童感染 COVID-19 的不良结局风险相对成人较低，但仍可从治疗干预中获益。了解儿童 COVID-19 的临床表现和预后对于优化治疗试验设计至关重要。本观点基于全球儿科配方药物加速开发组织的经验，阐述了如何共同加速儿科 COVID-19 治疗的研究和开发。
Zotero 插件